Compound ID | 501
Class: Bacterial topoisomerase inhibitor (2-hydroxyisoquinolone)
Spectrum of activity: | Gram-positive |
Institute where first reported: | Parke-Davis Pharmaceutical (Pfizer, USA) |
Year first mentioned: | 2000 |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://www.drugfuture.com/synth/syndata.aspx?ID=293726 |